Rektumkarzinom - Enddarmkrebs

ACO/ARO/AIO-18.2

• Status: aktiv
• Preoperative FOLFOX versus postoperative risk-adapted chemotherapy in patients with locally advanced rectal cancer and low risk for local failure: A randomized phase III trial of the German Rectal Cancer Study Group
• Kurzinformation
• Anprechpartner:
  Priv. Doz. Dr. med. Jan Peveling-Oberhag
  Telefon: 0711 278 54736
  E-Mail: j.peveling-oberhag@klinikum-stuttgart.de
• Studienzentrale
  Telefon: 0711 278 54961, -54539
  E-Mail: scc-studienzentrale@klinikum-stuttgart.de